Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2002
11/28/2002CA2445010A1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors
11/28/2002CA2443068A1 Veterinary compositions comprising avermectin-oxime derivatives and praziquantel
11/28/2002CA2441801A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002CA2427619A1 Pharmaceutically active isoindoline derivatives
11/28/2002CA2410628A1 Carbamic acid esters
11/28/2002CA2410391A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
11/27/2002EP1260591A1 High-efficiency assay for protein mannosyl transferases
11/27/2002EP1260590A1 Method of screening substance specifically inhibiting non-mevalonate pathway
11/27/2002EP1260587A2 Tyrosyl tRNA synthetase
11/27/2002EP1260512A1 Novel cyclic amide derivatives
11/27/2002EP1260504A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives
11/27/2002EP1260232A1 Remedies for malignant tumor-concomitant neurosis and azoor or analogous diseases thereof
11/27/2002EP1260226A1 Formulations containing iron ores for the topical treatment of bioenergetic and electromagnetic disorders
11/27/2002EP1260224A1 Sulfonyl pyridazinone compounds as therapeutic agents for ischemic tissue damage
11/27/2002EP1260210A1 Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
11/27/2002EP1259812A2 Breast, gastric and prostate cancer associated antigens and uses therefor
11/27/2002EP1259647A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
11/27/2002EP1259640A2 Methods and compositions for the screening of cell cycle modulators
11/27/2002EP1259638A2 Methods for selectively modulating survivin apoptosis pathways
11/27/2002EP1259621A2 Lipid metabolism enzymes
11/27/2002EP1259618A2 Human enzyme molecules
11/27/2002EP1259614A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2002EP1259605A2 Mutated cyclin g1 protein
11/27/2002EP1259603A2 Antisense oligonucleotides of the human chk1 gene and uses thereof
11/27/2002EP1259598A2 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/27/2002EP1259595A2 Integrin antagonists
11/27/2002EP1259548A1 Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
11/27/2002EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002EP1259525A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
11/27/2002EP1259515A2 Thienopyridine derivatives and their use as anti-inflammatory agents
11/27/2002EP1259514A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/27/2002EP1259512A1 Pteridine compounds for the treatment of psoriasis
11/27/2002EP1259510A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
11/27/2002EP1259508A1 Novel biarylcarboxamides
11/27/2002EP1259507A1 Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8 4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
11/27/2002EP1259506A1 Pyrazinone thrombin inhibitors
11/27/2002EP1259499A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors
11/27/2002EP1259494A1 Aryloxyacetic acids for diabetes and lipid disorders
11/27/2002EP1259491A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates and amides and their use as alpha-1a agonists
11/27/2002EP1259490A2 Synthesis of epothilones, intermediates thereto and analogues thereof
11/27/2002EP1259489A1 Aryl fused azapolycyclic compounds
11/27/2002EP1259488A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
11/27/2002EP1259487A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
11/27/2002EP1259482A2 Sulfur containing compounds
11/27/2002EP1259478A1 Covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids functionally active on the cb2 cannabinoid receptor
11/27/2002EP1259292A2 Therapeutic agents
11/27/2002EP1259262A1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
11/27/2002EP1259260A1 Combination therapy for the treatment of inflammatory and respiratory diseases
11/27/2002EP1259253A2 Methods for promoting production of myelin by schwann cells
11/27/2002EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4)
11/27/2002EP1259245A2 Novel compositions and uses of dictyostatin compounds
11/27/2002EP1259243A2 Bupropion metabolites and methods of their synthesis and use
11/27/2002EP1259242A2 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
11/27/2002EP1259241A1 The use of scopolamine salts
11/27/2002EP1259239A2 Use of cox-2 inhibitors as gastroprokinetics
11/27/2002EP1259237A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
11/27/2002EP1259236A1 Tyrosine kinase inhibitors
11/27/2002EP1259235A1 Tyrosine kinase inhibitors
11/27/2002EP1259234A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
11/27/2002EP1259231A2 Naphthoquinone derivatives as cd45 inhibitors
11/27/2002EP1259230A2 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure
11/27/2002EP1259223A1 Protein matrix materials, devices and methods of making and using thereof
11/27/2002EP1259121A2 Weight loss induced by reduction in neuropeptide y level
11/27/2002EP1259120A2 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof
11/27/2002EP1192152B1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
11/27/2002EP1180164A4 Methods using of fab i and compounds modulating fab i activity
11/27/2002EP1093369B1 Agent with an antidepressive effect comprising pramipexole and sertraline
11/27/2002EP1089742B1 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein
11/27/2002EP1073639B1 Quinoline derivatives
11/27/2002EP1059931B1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
11/27/2002EP1018338B1 Use of a retinoid type compound to increase in vivo the decoupling activity of the protein ucp2
11/27/2002EP1001934B1 Indole compounds as cox-2 inhibitors
11/27/2002EP1000048B1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
11/27/2002EP1000035B1 Substituted 6-phenylphenanthridines
11/27/2002EP0984915A4 Lutein esters having high bioavailability
11/27/2002EP0977564A4 Forskohlin for promoting lean body mass
11/27/2002EP0960110B8 3-ARYL SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES; CORTICOTROPIN-RELEASING FACTOR RECEPTOR (CRF1) SPECIFIC LIGANDS
11/27/2002EP0912554B1 Indoline derivatives useful as 5-ht-2c receptor antagonists
11/27/2002EP0862557B1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS
11/27/2002EP0783303B1 Use of aromatic halides for treating mammalian cell proliferation
11/27/2002EP0777471B1 Inhibition of leukotriene biosynthesis with urea derivatives
11/27/2002EP0776331B1 Higher order structure and binding of peptide nucleic acids
11/27/2002EP0765330B1 Lactam inhibitors of cholesterol esterase
11/27/2002EP0708648B1 Inhibition of nitric oxide production by retinoic acid
11/27/2002EP0630409B1 Defective packaging non-oncoviral vectors based on mpmv
11/27/2002EP0585267B1 Herpesvirus particle preparation and vaccine
11/27/2002CN1382211A Treatment of inflammatory or malignant disease using dnazymes
11/27/2002CN1382156A PABLO polypeptide that interacts with BCL-XL and uses related thereto
11/27/2002CN1382149A Hygromycin A prodrugs
11/27/2002CN1382146A Imidazole derivatives asphosphodiesterase VII inhibitors
11/27/2002CN1382144A Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382143A Inhibitors of alpha L beta 2 mediated cell adhesion
11/27/2002CN1382142A Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382141A 1,8-naphthyridine derivatives
11/27/2002CN1382138A Piperidine derivatives as reuptake inhibitors
11/27/2002CN1382137A Thtrahydrothiopy 2,3-diazanaphthylaone derivatives as PDE inhibitors
11/27/2002CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002CN1382135A Amine and amide derivatives as ligands for neuropeptide YY5 receptor usefu in treatment of obesity and other disorders
11/27/2002CN1382134A Benzopyranyl guanidine derivtives, process for preparation thereof and pharmaceutical compositions containing them
11/27/2002CN1382131A Substituted benzylthiazolidine-2,4-dione derivatives
1 ... 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 ... 1564